Oscar Health (NYSE:OSCR) Downgraded by Raymond James Financial to "Market Perform"

Raymond James Financial downgraded shares of Oscar Health (NYSE:OSCR - Free Report) from an outperform rating to a market perform rating in a report published on Tuesday, MarketBeat reports.

OSCR has been the topic of several other research reports. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Piper Sandler reduced their price objective on shares of Oscar Health from $25.00 to $18.00 and set an "overweight" rating for the company in a research report on Monday, June 9th. Finally, Wall Street Zen downgraded shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $16.50.

Oscar Health Trading Down 0.8%

NYSE OSCR traded down $0.17 on Tuesday, reaching $20.32. The company had a trading volume of 12,738,886 shares, compared to its average volume of 5,747,566. The firm has a market cap of $5.17 billion, a price-to-earnings ratio of 72.61 and a beta of 1.73. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The business has a 50 day moving average of $15.21 and a two-hundred day moving average of $14.60.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the previous year, the company earned $0.62 EPS. The company's revenue for the quarter was up 42.2% on a year-over-year basis. Analysts forecast that Oscar Health will post 0.69 EPS for the current year.

Insider Buying and Selling

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 24.39% of the stock is owned by company insiders.

Institutional Trading of Oscar Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Jones Financial Companies Lllp lifted its holdings in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio purchased a new stake in Oscar Health in the 1st quarter valued at $30,000. Larson Financial Group LLC lifted its stake in Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after acquiring an additional 2,512 shares in the last quarter. CWM LLC lifted its stake in Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after acquiring an additional 1,078 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Oscar Health by 484.6% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock worth $45,000 after acquiring an additional 2,854 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.